Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Durham, NC
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Eugene, OR
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Eugene, OR
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Springfield, OR
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Tualatin, OR
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Tualatin, OR
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Austin, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bedford, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Tyler, TX
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Newport News, VA
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Newport News, VA
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Vancouver, WA
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Vancouver, WA
Click here to add this to my saved trials
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated:  4/7/2016
mi
from
Arlon,
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
An Open-Label, Single-Arm, Multicenter Phase II Study of E7080 (Lenvatinib) in Subjects With Advanced Endometrial Cancer and Disease Progression Following First-Line Chemotherapy
Status: Enrolling
Updated: 4/7/2016
mi
from
Arlon,
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Chandler, AZ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Redlands, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Redlands, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Sacramento, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
San Luis Obispo, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Victorville, CA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Victorville, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Golden, CO
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Golden, CO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Littleton, CO
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Littleton, CO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bridgeport, CT
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Washington,
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Lakeland, FL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Lakeland, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Tampa, FL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Iowa City, IA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Ellsworth, ME
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Ellsworth, ME
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Cambridge, MA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Waltham, MA
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Waltham, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Detroit, MI
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Rochester, MN
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Jackson, MS
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
St. Louis, MO
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Omaha, NE
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Bloomfield, NJ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Bloomfield, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Palisades Park, NJ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Teaneck, NJ
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
New York, NY
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Belmont, NC
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Belmont, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Charlotte, NC
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated:  4/7/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
Status: Enrolling
Updated: 4/7/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials